Skip to main content
Drug Design, Development and Therapy logoLink to Drug Design, Development and Therapy
. 2020 Mar 13;14:1143. doi: 10.2147/DDDT.S252309

Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling [Corrigendum]

PMCID: PMC7082710  PMID: 32214799

Yu J, Zhu C, Yin J, et al. Drug Des Dev Ther. 2020;14:361–370.

The authors have advised that in Figure 3 on page 365, the image of the Blank group was mistakenly duplicated from the NC group. The correct figure is below.

Figure 3.

Figure 3

Tetrandrine inhibits TRPC6 overexpression-induced intracellular Ca2+ influx in MPC5 podocytes. Fluorescence image of fluo-3AM loaded cells (green) indicates intracellular Ca2+ influx. Differences were analyzed using one-way ANOVA. Significant differences with p < 0.05 are indicated by different letters. NC: containing blank lentivirus vector. blank:normal MPC5 podocyte. TRPC6 group: TRPC6-overexpressing.

The authors apologize for this error.


Articles from Drug Design, Development and Therapy are provided here courtesy of Dove Press

RESOURCES